(Reuters) -The U.S. Food and Drug Administration has approved Evita solution’s generic version of the abortion drug, mifepristone, the regulator said.
The drug is manufactured by privately-held company that describes its mission as being to “normalize abortion” and make it “accessible to all,” the FDA said in a letter dated September 30.
Evita will join GenBioPro to sell generic version of Danco Laboratories’ mifepristone, which is used for medication abortions up to 10 weeks of pregnancy.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Alan Barona)
